NCT05910047

Brief Summary

The goal of this randomized controlled double-blind parallel-group interventional trial is to evaluate the effects of dietary supplementation with molecular hydrogen and pyrroloquinoline quinone in elderly. The main questions it aims to answer are: (1) whether the supplementation affects biomarkers of mitochondrial function in serum, and (2) whether the supplementation affects cognition and brain metabolism. The participants will be subjected to take the dietary supplement during 6 weeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 8, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 18, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2024

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2024

Completed
Last Updated

December 4, 2024

Status Verified

December 1, 2024

Enrollment Period

7 months

First QC Date

June 8, 2023

Last Update Submit

December 3, 2024

Conditions

Keywords

MITOCHONDRIAL BIOMARKERSBRAIN METABOLISMCOGNITION

Outcome Measures

Primary Outcomes (1)

  • Fibroblast growth factor 21

    Level of fibroblast growth factor 21 in serum

    Change from baseline serum fibroblast growth factor 21 at 6 weeks

Secondary Outcomes (6)

  • Peroxisome proliferator-activated receptor gamma coactivator 1-alpha

    Change from baseline serum peroxisome proliferator-activated receptor gamma coactivator 1-alpha at 6 weeks

  • Brain-derived neurotrophic factor

    Change from baseline serum brain-derived neurotrophic factor at 6 weeks

  • Irisin

    Change from baseline serum irisin at 6 weeks

  • General cognition

    Change from baseline MMSE score at 6 weeks

  • Brain creatine

    Change from baseline brain creatine at 6 weeks

  • +1 more secondary outcomes

Study Arms (2)

Supplement

EXPERIMENTAL

One tablet of supplement before breakfast and dinner

Dietary Supplement: Supplement

Placebo

PLACEBO COMPARATOR

One tablet of inert compound before breakfast and dinner

Dietary Supplement: Placebo

Interventions

SupplementDIETARY_SUPPLEMENT

Dietary supplement containing molecular hydrogen and pyrroloquinoline quinone

Supplement
PlaceboDIETARY_SUPPLEMENT

Inert substance

Placebo

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age \> 65 years
  • MMSE scores ranged from 23-27
  • Informed consent signed

You may not qualify if:

  • Take part in exercise on a regular basis
  • Severe chronic disease and acute injuries
  • History of dietary supplement use during the past 4weeks
  • No consent to randomization
  • Participation in other studies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

FSPE Applied Bioenergetics Lab

Novi Sad, Vojvodina, 21000, Serbia

Location

Related Publications (5)

  • Zanini D, Todorovic N, Korovljev D, Stajer V, Ostojic J, Purac J, Kojic D, Vukasinovic E, Djordjievski S, Sopic M, Guzonjic A, Ninic A, Erceg S, Ostojic SM. The effects of 6-month hydrogen-rich water intake on molecular and phenotypic biomarkers of aging in older adults aged 70 years and over: A randomized controlled pilot trial. Exp Gerontol. 2021 Nov;155:111574. doi: 10.1016/j.exger.2021.111574. Epub 2021 Oct 1.

    PMID: 34601077BACKGROUND
  • Ostojic SM. Does drinking water rich in hydrogen gas revive brain hypometabolism in neurodegeneration by SCFAs upregulation? Eur J Clin Nutr. 2021 Jan;75(1):212-213. doi: 10.1038/s41430-020-0680-x. Epub 2020 Jul 6. No abstract available.

    PMID: 32632247BACKGROUND
  • Korovljev D, Stajer V, Javorac D, Ostojic SM. Hydrogen inhalation positively affects cardiometabolic risk factors in men and women aged 65 years or older: a preliminary report. Eur Geriatr Med. 2018 Oct;9(5):729-730. doi: 10.1007/s41999-018-0087-6. Epub 2018 Jul 31. No abstract available.

    PMID: 34654221BACKGROUND
  • Korovljev D, Trivic T, Drid P, Ostojic SM. Molecular hydrogen affects body composition, metabolic profiles, and mitochondrial function in middle-aged overweight women. Ir J Med Sci. 2018 Feb;187(1):85-89. doi: 10.1007/s11845-017-1638-4. Epub 2017 May 30.

    PMID: 28560519BACKGROUND
  • Ostojic SM. Targeting molecular hydrogen to mitochondria: barriers and gateways. Pharmacol Res. 2015 Apr;94:51-3. doi: 10.1016/j.phrs.2015.02.004. Epub 2015 Feb 24.

    PMID: 25720951BACKGROUND

MeSH Terms

Interventions

Dietary Supplements

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 8, 2023

First Posted

June 18, 2023

Study Start

September 1, 2023

Primary Completion

March 15, 2024

Study Completion

March 31, 2024

Last Updated

December 4, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

Data obtained through this study may be provided to qualified researchers with academic interest in age-related mild cognitive impairment. Data will be coded, with no PHI included. Approval of the request and execution of all applicable agreements are prerequisites to the sharing of data with the requesting party.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Data requests can be submitted starting 9 months after article publication and the data will be made accessible for up to 24 months. Extensions will be considered on a case-by-case basis.

Locations